Verine

Quick links to important sections

Verine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Verine

Property Description
Active Ingredient Mebeverine Hydrochloride
Form Tablets, Sustained-Release (SR) Capsules
Pharmacological Class Musculotropic Antispasmodic Agent
General Purpose Relief of intestinal spasms and cramping
Origin Synthetic Compound (Papaverine derivative)

What Type of Medicine is Verine?

Verine is a recognized trade name for the active pharmaceutical ingredient, Mebeverine Hydrochloride. This substance is scientifically classified as a musculotropic antispasmodic agent. Mebeverine is a synthetic compound, derived as a second-generation analog of the substance Papaverine, engineered specifically to address muscle overactivity within the gastrointestinal system. This classification signifies that its primary action is direct muscle relaxation, differentiating it from agents that act primarily on the nervous system.


Composition and Available Forms

This medication is a single-ingredient product where Mebeverine Hydrochloride is the sole active substance. It is formulated for oral administration and is typically supplied as standard tablets or as specialized sustained-release (SR) capsules. The key difference between these forms is their delivery mechanism: the SR capsule is designed to release the drug slowly over time, providing a more consistent level of relief throughout the day. This extended-release profile is associated with providing convenience in managing chronic discomfort.


General Purpose and Mechanism Summary

The general purpose of Verine is to alleviate the pain and cramping associated with the excessive, uncoordinated movement of muscles within the gut. Mebeverine achieves this by exerting a direct action on the smooth muscle lining the intestinal walls, promoting muscle relaxation and helping to stabilize the hyperactive state of the bowels. This specific mechanism helps counter the sudden, painful spasms experienced in the lower abdomen, thereby addressing the root cause of the discomfort.

What side effects are possible with Verine?

Possible Side Effects and Safety Information

The safety profile of Mebeverine Hydrochloride (Verine) is primarily documented through post-marketing surveillance. The officially documented adverse reactions are largely confined to hypersensitivity reactions (allergic responses).


Officially Documented Adverse Reactions

Adverse reactions have been grouped into two main System-Organ Classes in regulatory documents:

  • Immune system disorders: These reactions include general hypersensitivity and the potential for a serious adverse reaction known as an anaphylactic reaction.
  • Skin and subcutaneous tissue disorders: Manifestations of allergic responses include urticaria (hives), angioedema (swelling beneath the skin), face oedema, and exanthema (skin rash).

For all these reported events, the official frequency classification is not known, meaning a precise incidence rate cannot be estimated from the available spontaneous reporting data.


Safety Considerations and Restrictions

Official labeling includes specific constraints regarding the use of this medication:

  • Children and Adolescents: Use is not recommended for those under 18 years of age due to insufficient data on safety and effectiveness in this population.
  • Pregnancy and Lactation: The medication is not recommended during pregnancy and should not be used during breastfeeding as information on its excretion in human milk is not available.
  • Contra-indications: The medication is contra-indicated for individuals with known hypersensitivity to the active substance or any of its inactive ingredients. Furthermore, formulations containing certain sugars (such as lactose) are contra-indicated for patients with specific hereditary sugar intolerances (e.g., galactose intolerance).

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that urgent medical attention is required if an overdose of Mebeverine Hydrochloride (Verine) is suspected. It is crucial to contact a doctor or seek hospital care immediately, bringing the medication package.

Official Overdose Profile

Regulatory documentation describes the observed clinical picture of overdose as generally mild and usually rapidly reversible. The documented manifestations are categorized as being of a neurological nature and a cardiovascular nature.

  • Severity Classification: The majority of reported symptoms are classified as mild.
  • Affected Systems: Regulatory labels note the involvement of neurological and cardiovascular systems; CNS excitability is listed as a theoretical manifestation in cases of significant overexposure.

Regulatory Management and Action

Treatment of an overdose is strictly defined as symptomatic and supportive. Regulatory authorities mandate that the patient's vital functions must be monitored closely by medical personnel.

  • Antidote Status: No specific antidote is known or available for this substance.
  • Procedural Notes: Routine absorption reducing measures are not necessary. Procedures such as gastric lavage may be considered only in specific contexts, such as an ingestion discovered within approximately one hour or cases of multiple intoxication.

Therapeutic Uses of Verine

Main Uses of Verine

Verine, containing the active ingredient mebeverine hydrochloride, is a type of medicine known as an antispasmodic. It is primarily used to manage symptoms associated with functional bowel disorders, most notably irritable bowel syndrome (IBS).

The medication is designed to act directly on the smooth muscles of the gastrointestinal tract, particularly the colon. By helping these muscles relax, it assists in normalizing bowel movement patterns without interfering with the natural nervous system functions of the gut.

Conditions Managed

Verine is typically utilized to address various symptoms that occur when the muscles in the gut wall go into spasm. These include:

  • Abdominal Pain and Cramping: Reducing the intensity and frequency of painful stomach cramps.
  • Persistent Diarrhea: Helping to manage frequent, loose stools associated with bowel hypermotility.
  • Alternating Bowel Habits: Assisting patients who experience fluctuations between constipation and diarrhea.
  • Flatulence and Bloating: Relieving the sensation of fullness and gas-related discomfort.
  • Small Stools: Addressing the production of hard, pellet-like stools often seen in IBS flare-ups.

Benefits and Clinical Goals

The primary goal of Verine use is the symptomatic relief of intestinal spasms. Unlike some other medications that affect the entire body, Verine acts locally on the digestive system, which helps limit systemic effects.

Improving Quality of Life

By targeting the underlying muscle spasms, Verine aims to restore a sense of normalcy to the digestive process. For many individuals, managing the unpredictable nature of IBS symptoms allows for improved comfort during daily activities and reduced physical distress associated with meals or stress-triggered episodes.

Key Therapeutic Advantages

  • Targeted Action: It works specifically on the muscle fibers of the gut wall.
  • Muscle Relaxation: It helps the digestive tract move food through the system more smoothly by preventing over-contraction.
  • Suitability for Chronic Conditions: Because IBS is often a long-term condition, Verine provides a specialized option for addressing recurrent spasmic episodes.

Eligibility and Restrictions for Use

The eligibility for using Verine is strictly defined by regulatory documents, identifying specific populations who may use the medicine and those who must not.

Eligibility Scope Official Regulatory Status
Populations for Use Adults (18 years and older), including the elderly.
Use Not Recommended Children and adolescents below 18 years.
Absolute Contraindications Hypersensitivity to mebeverine hydrochloride or excipients.

Use is contraindicated for patients with a known hypersensitivity to the active substance or to any non-active ingredients. This prohibition also extends to individuals with specific hereditary metabolic disorders such as galactose intolerance or total lactase deficiency due to the presence of excipients like lactose in the formulation.

Regarding age, Verine is not recommended for use in children and adolescents below 18 years, a classification based on regulatory findings of insufficient data on safety and efficacy for this age group.

For reproductive populations, use is not recommended during pregnancy and should not be used during breast-feeding, as official data regarding safety and excretion in human milk is either limited or unavailable. While no dosage adjustment is deemed necessary for patients with renal or hepatic impairment, official documents note that formal posology studies were not performed in these populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Verine (Mebeverine Hydrochloride) exhibits a profile with limited documented interaction potential based on official regulatory prescribing information. Most labels consistently state that no drug-drug interactions are known because formal interaction studies with other medicinal products have not been performed.

Interaction Scope and Metabolism

The low potential for systemic interactions is supported by the drug’s primary metabolic pathway. Verine is mainly metabolized via esterase hydrolysis, splitting the compound into various metabolites. This route avoids the Cytochrome P450 (CYP) enzyme system, which minimizes the risk of common pharmacokinetic interactions involving CYP enzyme inhibition or induction.

Consequently, official regulatory documents do not list any specific medicinal products as formally contraindicated due to interaction risk. No mandatory timing or separation rules are documented for co-administration with other substances.

Documented Product Interactions

The only product interaction specifically addressed in the regulatory profile is with ethanol (alcohol). Official studies have demonstrated the absence of any interaction between mebeverine hydrochloride and alcohol.

No specific interaction risks have been identified from post-marketing data that necessitate dosage adjustment or additional caution for special populations, including the elderly or patients with renal or hepatic impairment.

Mechanism of Action

Mechanism of Action of Mebeverine

Mebeverine modulates smooth muscle activity through a direct and localized mechanism targeting the cellular components of the gastrointestinal smooth muscle. This action is achieved by influencing the ion fluxes essential for muscle cell excitation and contraction.

Ion Channel Modulation: Controlling Cellular Excitability

The primary action involves dual modulation of ion channels critical for initiating and sustaining muscle contraction. Mebeverine acts as a blocker of Voltage-Operated Sodium Channels (VoNa^+) and an inhibitor of Calcium ion influx (Ca^2+) into the smooth muscle cell cytoplasm. This interference with both the electrical (sodium) and chemical (calcium) signals results in decreased cell excitability and a reduced capacity for sustained contraction.

Localized Myolytic Activity and Physiological Consequence

The reduction in cellular excitability results in a change in smooth muscle tone classified as myolytic activity, characterized by muscle fiber relaxation. The mechanism demonstrates high peripheral localization to the gastrointestinal system. Its activity is preferential toward hypercontractile muscle states, with minimal influence observed on normal, coordinated peristaltic movement.

Dosage and Administration Information

Verine (Mebeverine Hydrochloride) is administered by the oral route and is available in distinct formulations that establish its official usage pattern. The medicine is commonly supplied as a 135 mg film-coated tablet or a 200 mg modified-release (MR) capsule. These two forms dictate the official frequency of administration, with the standard 135 mg tablet typically taken three times a day, and the 200 mg MR capsule scheduled for twice daily administration.

A key procedural instruction across all forms is that the medicine must be taken preferably 20 minutes before a meal. The tablets and capsules must be swallowed whole with a sufficient amount of water and should not be chewed or crushed. This requirement is necessary to ensure the integrity of the release mechanism. The maximum daily dose should not exceed three 135 mg tablets or two 200 mg capsules.

The duration of use is not strictly limited, and the regimen may involve a gradual dose reduction once the desired effect has been sustained for several weeks. If a scheduled dose is missed, the instruction is to skip that dose entirely and continue with the next planned intake; patients must not take a double dose to compensate. Dosing adjustments are generally not considered necessary for older adults or those with existing renal or hepatic impairment, though use is not typically recommended in children and adolescents under 18 years.

Recent Clinical Evidence

Recent Clinical Evidence for Verine

Clinical research has focused on investigating Verine (VER-01), a standardized full-spectrum extract, primarily in adults with Chronic Low Back Pain (CLBP). A recent Phase 3 randomized controlled trial (RCT) examined the effect of Verine compared to opioid treatment over a six-month period. The research design focused on assessing both pain outcomes and gastrointestinal tolerability, which was defined as the primary endpoint.

Study Findings and Tolerability

  • Gastrointestinal Tolerability: In the reviewed trials, participants receiving Verine were reported to be less likely to experience constipation compared to those in the opioid arm, indicating a difference in gastrointestinal adverse events.
  • Pain and Sleep Outcomes: The trial assessed changes in pain and sleep quality using the Numeric Rating Scale (NRS). Longitudinal analysis of the six-month treatment period reported a difference in the mean pain reduction score in favor of the Verine group compared to the opioid group. An associated difference in self-reported sleep improvement was also observed.
Outcome Type Research Observation Comparison
Tolerability Lower reported occurrence of constipation. Compared to opioid group.
Pain Reported difference in mean pain reduction over six months. Compared to opioid group.
Sleep Quality Reported difference in sleep improvement score. Compared to opioid group.

Verine continues to be the subject of clinical assessment to explore its role in managing chronic pain conditions and other related symptoms. Ongoing research seeks to clarify its long-term profile and therapeutic utility.

Frequently Asked Questions (FAQ)

Common questions about Verine (FAQ)


Q: Are there different strengths or dosages of Verine available?

Official regulatory documentation describes the active ingredient in two primary formulations. These include a 135 mg film-coated tablet and a 200 mg modified-release (MR) capsule. These are the standard forms used to establish the official prescribing patterns.


Q: Is it necessary to take Verine at the exact same time every day?

Official administration instructions emphasize taking the medicine before a meal (preferably 20 minutes) and following a scheduled frequency, such as twice or three times daily, for consistent management. Regulatory documents focus on the relationship to meals and the regular schedule, but do not specifically mandate taking it at the exact same time each day.


Q: What is the risk of overdose with Verine?

Reports of overdose are limited in official sources, and symptoms are generally described as mild, absent, and rapidly reversible. Observed symptoms have been reported to be of a neurological nature, such as central nervous system (CNS) excitability.


Q: Is there any research about Verine's effect on sleep patterns?

While the drug's primary function is localized to the gut, official regulatory documents and post-marketing data have cited difficulty sleeping (insomnia) as a reported, though infrequent, adverse effect. Some clinical studies have included the measurement of sleep outcomes.


Q: Is it mandatory to have a discussion with a healthcare provider about all risks before starting Verine?

Official labeling and patient leaflets consistently advise users to consult with a healthcare provider if they have certain pre-existing conditions (e.g., liver or kidney problems) or experience new or worsening symptoms. Regulatory guidance suggests a professional consultation is important to review the official contraindications and risks.


Q: Does Verine have different brand names in other countries?

Yes, it does. Verine's active ingredient, Mebeverine Hydrochloride, is a generic compound that is available internationally and is marketed under multiple different brand names (trade names) across various global regions.


Q: Why is Verine considered a prescription-only medicine?

The drug is officially classified as a Prescription-Only Medicine (POM) in many jurisdictions, such as the UK. This classification is typically assigned based on the need for a healthcare professional to diagnose the underlying condition and oversee the use of the medicine.


Q: Is Verine a type of antibiotic?

No. Verine is officially classified as a musculotropic antispasmodic agent. This classification means its effect is focused on relaxing the smooth muscle in the gut to reduce painful spasms, and it is not an anti-infective medicine like an antibiotic.


Q: How quickly can I expect Verine to start working?

Regulatory documents indicate that the medicine is rapidly absorbed after oral administration. Clinical studies report that the time for the main metabolite to reach its maximum concentration (T max) in the body is approximately 1 to 3 hours after administration.


Q: How long does it typically take for Verine to leave the body?

The active substance is completely metabolized in the body. The main circulating metabolite has a steady-state elimination half-life reported in regulatory documents to be approximately 2.45 hours. The metabolites are then nearly completely excreted from the body via the urine.


Q: Can Verine be stopped suddenly, or does it need to be tapered?

Official documents state that the dose regimen may involve a gradual dose reduction once the desired effect has been sustained for several weeks. While abrupt discontinuation is not prohibited for everyone, a gradual reduction is a defined practice when discontinuing use over a period of weeks.


Q: Why do some people say they use Verine for things other than its main purpose?

Official documents define the medicine’s authorized use based strictly on regulatory review and clinical trials. Medical uses beyond those described in the official labeling are considered off-label and are not discussed or supported by official sources.


Q: What is the longest period someone might be prescribed to take Verine?

Regulatory documents indicate that the duration of use is not strictly limited. The regimen may be adjusted based on the individual’s long-term response.


Q: Does Verine affect performance when driving or operating machinery?

Official patient information explicitly states that this medicine is not likely to affect the user’s ability to drive or operate machinery. Official labeling advises users to be aware of how they react to the medicine before driving or operating machinery.


Q: Are there specific vitamins or supplements that should not be taken with Verine?

Official regulatory documents indicate that formal interaction studies with other medicines or supplements have not been performed. The drug's metabolism profile, which avoids the CYP enzyme system, suggests a low potential for systemic interactions. Consultation about concurrent use of other remedies is generally appropriate.


Q: Is it okay to drink coffee or tea while taking Verine?

Official regulatory documents do not list any specific contraindication or mandatory separation rule regarding the co-administration of Verine with coffee or tea. The only substance with documented information is ethanol (alcohol), which showed no interaction.


Q: Can Verine cause changes in appetite or weight?

Post-marketing data and some patient leaflets have reported loss of appetite as an observed side effect of the medicine. However, the official regulatory safety profile does not specifically list 'weight change' as a reported adverse reaction.


Q: Can Verine be taken by people who have liver problems?

Official documents state that dosage adjustments are generally not considered necessary for patients with existing hepatic (liver) impairment. However, official documents note that use in severe cases requires careful consideration.


Q: Does Verine affect kidney function in healthy adults?

The medicine is extensively metabolized and the metabolites are primarily excreted via the urine. Dosage adjustments are not considered necessary for patients with existing renal (kidney) impairment, and no specific adverse effects on healthy kidneys are documented in official profiles.


Q: Is Verine a controlled substance?

No. The active ingredient, Mebeverine Hydrochloride, is classified as a musculotropic antispasmodic agent. It is not scheduled as a controlled substance in major regulatory jurisdictions, meaning its use is not subject to special legal restrictions.


Q: Why are people with certain heart conditions advised not to take Verine?

While specific heart conditions are not listed as an official contraindication, the observed symptoms of overdose have on occasion included effects of a cardiovascular nature (e.g., bradycardia). This suggests caution may be necessary in individuals with existing heart conditions.


Q: Is feeling tired a common side effect of Verine?

Official regulatory adverse event data is largely confined to hypersensitivity reactions. However, post-marketing data and patient leaflets have reported tiredness (fatigue) as an observed, non-serious side effect, though the frequency is not known.


Q: Can Verine be taken with an upset stomach?

Official instructions specify taking the medicine preferably 20 minutes before a meal to allow for proper absorption and action. There is no specific instruction in regulatory documents about administration with an existing upset stomach.


Q: Does Verine affect blood pressure?

Adverse events reported during overdose have occasionally included effects of a cardiovascular nature. However, no specific effect on blood pressure is listed in the official table of adverse reactions or the primary side effect profile.


Q: Are there common misunderstandings about how Verine works?

The official mechanism is described as a direct musculotropic antispasmodic action on the smooth muscle lining the gut wall. A key point of clarification is that its activity is localized and does not primarily affect the central nervous system (CNS) like some other types of spasmolytics.


Q: Does taking Verine require frequent check-ups with a doctor?

Official guidance on long-term use notes that the regimen may involve dose adjustments and a gradual reduction over time, which implies the need for ongoing monitoring. However, the specific frequency of check-ups is not mandated by regulatory bodies.


Q: Can Verine cause sensitivity to sunlight?

The officially documented adverse reactions are limited to hypersensitivity and skin reactions like urticaria and rash. Sensitivity to sunlight (photosensitivity) is not listed as an officially reported side effect in regulatory documents.


Q: Is there a generic version of Verine available?

Yes. Verine's active ingredient, Mebeverine Hydrochloride, is classified as a generic drug. This means the active ingredient is available under multiple names.


Q: Does Verine affect mood or emotional state?

Reported overdose symptoms have been noted to be of a neurological nature, and patient information sometimes mentions difficulty in sleeping. Any observed changes in emotional state are typically discussed with a healthcare provider.


Q: Why is the mechanism of action for Verine described in complex chemical terms?

The official mechanism is defined by its action on specific muscle cell components, involving terms like Voltage-Operated Sodium Channels and Calcium ion influx. This technical language is necessary for scientific clarity when describing the precise, localized effect on the cellular environment to healthcare professionals.


Q: Does Verine interact with herbal supplements like St. John's Wort?

Official regulatory documents indicate that formal interaction studies with other medicines or herbal supplements have not been performed. For this reason, the use of such supplements is often discussed with a healthcare provider, as the full interaction potential is not formally established.


Q: Does Verine have known effects on fertility?

Official documents state that there are no clinical data regarding the drug's impact on male or female fertility in humans. However, available animal studies do not indicate harmful effects on fertility when used at clinically relevant doses.

How should Verine be stored and disposed of?

How to Store and Dispose of Verine (Mebeverine Hydrochloride)

Mebeverine Hydrochloride must be stored strictly according to official regulatory conditions to maintain stability.

Storage Requirements

The medicine must be kept out of the sight and reach of children and stored in the original package. Tablets require storage in a dry place and must be protected from light. The temperature must not exceed 30 C, and certain formulations are explicitly labeled not to be refrigerated or frozen. For some container types, the product must be discarded 90 days after the first opening.


Disposal Instructions

All unused or expired product must be handled in accordance with local requirements. Regulatory instructions prohibit discarding the medicine via wastewater or general household waste, necessitating return to a designated collection point for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Verine found in:

A-Z Index: